These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 16247783)

  • 1. Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.
    Salmon E; Perani D; Herholz K; Marique P; Kalbe E; Holthoff V; Delbeuck X; Beuthien-Baumann B; Pelati O; Lespagnard S; Collette F; Garraux G
    Hum Brain Mapp; 2006 Jul; 27(7):588-97. PubMed ID: 16247783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation.
    Tagai K; Shinagawa S; Kada H; Inamura K; Nagata T; Nakayama K
    Psychogeriatrics; 2018 Mar; 18(2):81-88. PubMed ID: 29409154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Awareness of deficits and anosognosia in Alzheimer's disease].
    Antoine C; Antoine P; Guermonprez P; Frigard B
    Encephale; 2004; 30(6):570-7. PubMed ID: 15738860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dorsomedial prefrontal metabolism and unawareness of current characteristics of personality traits in Alzheimer's disease.
    Jedidi H; Feyers D; Collette F; Bahri MA; Jaspar M; d'Argembeau A; Salmon E; Bastin C
    Soc Cogn Affect Neurosci; 2014 Oct; 9(10):1458-63. PubMed ID: 23946004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two aspects of impaired consciousness in Alzheimer's disease.
    Salmon E; Ruby P; Perani D; Kalbe E; Laureys S; Adam S; Collette F
    Prog Brain Res; 2005; 150():287-98. PubMed ID: 16186031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anosognosia and default mode subnetwork dysfunction in Alzheimer's disease.
    Antoine N; Bahri MA; Bastin C; Collette F; Phillips C; Balteau E; Genon S; Salmon E
    Hum Brain Mapp; 2019 Dec; 40(18):5330-5340. PubMed ID: 31444942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
    Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
    Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    Weissberger GH; Melrose RJ; Fanale CM; Veliz JV; Sultzer DL
    J Alzheimers Dis; 2017; 60(2):707-719. PubMed ID: 28869474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between anosognosia and regional cerebral blood flow in Alzheimer's disease.
    Shibata K; Narumoto J; Kitabayashi Y; Ushijima Y; Fukui K
    Neurosci Lett; 2008 Apr; 435(1):7-10. PubMed ID: 18353553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory impairment and awareness of memory deficits in early-stage Alzheimer's disease.
    Mimura M; Yano M
    Rev Neurosci; 2006; 17(1-2):253-66. PubMed ID: 16703956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease.
    Senturk G; Bilgic B; Arslan AB; Bayram A; Hanagasi H; Gurvit H; Emre M
    Int Psychogeriatr; 2017 Feb; 29(2):293-302. PubMed ID: 27780496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
    Auning E; Selnes P; Grambaite R; Šaltytė Benth J; Haram A; Løvli Stav A; Bjørnerud A; Hessen E; Hol PK; Muftuler løndalen A; Fladby T; Aarsland D
    Acta Psychiatr Scand; 2015 Feb; 131(2):139-47. PubMed ID: 25346330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of amyloid deposition in patients with mild cognitive impairment.
    Forsberg A; Engler H; Almkvist O; Blomquist G; Hagman G; Wall A; Ringheim A; Långström B; Nordberg A
    Neurobiol Aging; 2008 Oct; 29(10):1456-65. PubMed ID: 17499392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosognosia: patients' distress and self-awareness of deficits in Alzheimer's disease.
    Maki Y; Amari M; Yamaguchi T; Nakaaki S; Yamaguchi H
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):339-45. PubMed ID: 22815083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.